Introduction
============

Hip fractures are an important cause of hospitalization in elderly people and, even those with major comorbidities, are in need of surgical intervention. The number of persons aged \>70 will double within the next three decades, which will result in an increase in the incidence of hip fractures.[@b1-cia-12-421]

More than any other type of fracture, a hip fracture in elderly is associated with loss of independence, high morbidity and mortality (36%), and high health care costs.[@b2-cia-12-421]

A major complication in elderly hip fracture patients is delirium, with an incidence rate varying from 13% to 70%.[@b3-cia-12-421]--[@b6-cia-12-421] Postoperative delirium is associated with poor outcomes, such as impaired functional and cognitive recovery, increased hospital length of stay, higher costs, and increased mortality.[@b3-cia-12-421]--[@b12-cia-12-421]

No strong evidence exists on the treatment of delirium.[@b13-cia-12-421],[@b14-cia-12-421] However, Inouye et al[@b8-cia-12-421] stated that in the general geriatric population, 30% to 40% of the delirium episodes could be prevented by treatment of the risk factors. Several other studies were performed on delirium prevention in hip fracture patients, but the evidence remains weak.[@b14-cia-12-421]--[@b16-cia-12-421] Orthogeriatric care for example has been described as an effective treatment for this patient group, but delirium was not always taken into account or the evidence was weak.[@b17-cia-12-421],[@b18-cia-12-421] Furthermore, a diversity of risk factors has been described in a heterogeneous group of patients and studies. Most studies were conducted on frail elderly, cardiothoracic surgery patients, patients admitted to long-term facility care or intensive care unit (ICU).[@b19-cia-12-421]--[@b22-cia-12-421]

Dementia is one of the most important risk factors for delirium in the elderly and its prevalence is increasing.[@b23-cia-12-421] The effects of dementia on the outcome after delirium (delirium superimposed on dementia) have been rarely described and, to the best of our knowledge, never in elderly hip fracture patients.[@b24-cia-12-421],[@b25-cia-12-421]

The goal of this study was to add to the previous knowledge on the risk factors for delirium in elderly hip fracture patients. In addition, this study investigated the effects of dementia on delirium and the outcomes after an episode of delirium in this patient category.

Patient and methods
===================

Patient selection
-----------------

Ethical approval was deemed unnecessary by the institutional review board of the Amphia hospital due to its retrospective nature. Written consent was also deemed unnecessary by the institutional review board. Patients aged ≥70 years with an isolated hip fracture were included between January 1, 2014 and August 31, 2015 at the Amphia Hospital, Breda, the Netherlands. Patients included in this study underwent hip replacement therapy or osteosynthesis. In the event of a second hip fracture during the course of this study, data related to only the first hip fracture was used.

A hip fracture was defined as proximal femur fracture and classified according to the Arbeitsgemeinschaft für Osteo-synthesefragen (AO) classification: 31 A or 31 B. Femoral head fractures (AO 31 C) were not included.

Patients with a pathological or a peri-prosthetic hip fracture, as well as patients with multiple traumatic injuries and high-energy trauma were excluded.

The follow-up was documented by physicians and registered nurses. All study parameters were collected in an electronic patient file system: Hyperspace Version IU4 (Epic, Inc., Verona, WI, USA). Data were collected in validated scoring systems used in the electronic patient file, eg, Katz Index of Independence in Activities of Daily Living (Katz-ADL), Short Nutritional Assessment Questionnaire for Residential Care, Mini Nutritional Assessment Short-Form, or Delirium Observational Screening Scale (DOSS) screening score. All data were analyzed retrospectively.

The follow-up was 6 months or until death. Date of mortality was retrieved from the CompeT&T database (Eindhoven, the Netherlands).

Preoperative data
-----------------

Patient characteristics, sex, age, comorbidity, and factors of frailty were documented. Burden of comorbidity was assessed by the Charlson comorbidity index (CCI) and American Society of Anesthesiology (ASA) physical status classification.[@b26-cia-12-421],[@b27-cia-12-421]

The CCI categorizes comorbidities and weighs them from 0 to 6, with 6 having the highest chance for mortality. Age is also included with 1 point for each decade since the age of 50. The sum of all the factors results in the CCI score.[@b28-cia-12-421]

The presence of the following comorbidities was registered, these were grouped as follows: 1) previous hip fracture; 2) presence of cardiac morbidity (eg, arrhythmia, myocardial infarction, heart failure, valve insufficiency or stenosis, acute coronary syndrome, and coronary artery bypass graft); 3) pulmonary morbidity (eg, chronic obstructive pulmonary disease, emphysema, tuberculosis, asthma, lung cancer, and lung embolus); 4) neurological morbidity (eg, cerebrovascular accident or transient ischemic attack, epilepsy, Parkinson, meningioma, subarachnoid bleeding); 5) renal insufficiency; 6) previous delirium and dementia; 7) presence of diabetes; and 8) osteoporosis. Also the use of anticoagulants was registered. The duration of admission until surgical intervention was noted.[@b29-cia-12-421]

Factors of frailty
------------------

Nutritional status was assessed using the Short Nutritional Assessment Questionnaire for Residential Care score, which is based on the body mass index, loss of weight and reduced appetite, and need of help with eating. A cut-off of 3 points or more was used to indicate severe undernourishment.[@b30-cia-12-421]

Physical impairment was evaluated using the Katz-ADL score. The Katz-ADL scores physical performances: bathing, dressing, toileting, transfers, feeding, and continence. Less than 6 points indicated functional impairment and \<2 points indicated severe functional impairment.[@b31-cia-12-421]

Social status and living arrangement, use of alcohol, vision, and hearing problems were scored.

Treatment
---------

The following procedures were performed for hip fracture repair: inter- or subtrochanteric fractures (AO 31 A types) were repaired by a gamma nail (Stryker Corporation^®^, Kalamazoo, MI, USA) or a dynamic hip screw (Depuy-Synthes^®^, PA, USA).

Intracapsular fractures (AO 31 B types) were treated with either osteosynthesis (dynamic hip screw, a dynamic locking blade plate (Gannet^®^, Groningen, the Netherlands) or Depuy-Synthes cannulated screws) or hemi- or total arthroplasty.

Information was collected concerning the type of surgery, type of anesthesia, duration of anesthesia (intubation and extubation time), blood loss (mL), and events which occurred during surgery. All the patients had received preoperative prophylactic antibiotics.

Primary outcome
---------------

The DOSS was used to screen for postoperative delirium (POD). DOSS were taken daily during each nurse shift. A DOSS ≥3, during three or more nurse working shifts in a row, was considered as highly specific for delirium and a criterion to consult a geriatrician. This was also done in case there was any doubt about the diagnosis, and in patients with dementia. For the current study, the clinical notes of the geriatric department were analyzed to confirm the diagnosis of delirium.

Delirium duration was defined as the number of days with DOSS ≥3.[@b32-cia-12-421],[@b33-cia-12-421] If a patient was discharged with high DOSS (≥3), the duration of the delirium was counted until the day of discharge.

Use of prophylactic or therapeutic medication (eg, haloperidol, lorazepam, or seroquel) was started by protocol and noted. The physician could deviate from the protocol.

Other postoperative outcomes
----------------------------

Adverse events were divided into surgery-related events (eg, wound infection, postoperative bleeding, hardware failure of open reduction internal fixation material or prosthetic luxation after hip replacement and a new hip fracture within 6 months) and medical events (eg, cardiac, urinary, neurological, or pulmonary).

Data were gathered on ICU admission, the duration of hospital stay (excluding in-hospital mortality patients), ane-mia, and the amount of administered packed cells. Packed cells were indicated when hemoglobin level was \<5 mmol/L (8 g/dL) in patients \>60 years in the general population and \<6 mmol/L (9.7 g/dL) in patients with cardiac conditions or symptomatic anemia.[@b34-cia-12-421]

Mortality within 6 months after surgery, location of discharge (home with or without care or institutionalization) was described.

Statistical analysis
--------------------

Frequencies and descriptive statistics were used for reporting the baseline characteristics of the variables in our study population.

Differences in categorical variables between patients with or without delirium were presented as frequencies with percentages and tested using the chi-square test or Fisher's exact test. The Kolmogorov--Smirnov test was used to define normal distribution for continuous variables. Differences in continuous variables were presented as medians (interquartile ranges \[IQR\]) or means (standard deviation) and were tested using the Mann--Whitney *U*-test or Student's *t*-test, respectively.

Length of delirium with respect to medication was compared using the Kruskal--Wallis test.

To perform a univariate risk analysis of risk factors related to the incidence of delirium, odds ratios with 95% confidence interval were used. Multivariate analysis was done, using logistic regression to correct for confounder (if the rule of thumb was not violated). All significant risk factors were adjusted for age. Survival rates were calculated using Kaplan--Meier analysis, and differences with respect to subgroups were analyzed using the Log-rank test.

A *P*-value \<0.05 was considered significant. Statistical analysis was performed with SPSS Version 23.0 (SPSS Inc., Chicago, IL, USA) software.

Results
=======

Baseline clinical characteristics
---------------------------------

[Table 1](#t1-cia-12-421){ref-type="table"} shows all baseline preoperative characteristics. Data of 566 included patients were extracted from the electronic patient files. Of these patients, 425 patients (75%) were females and the median age was 84 years (IQR: 9). The ASA score of 3 was most often documented (364 patients, 63.3%) and the median CCI was 6 (IQR: 2). The majority of the patients had an intracapsular fracture (58%).

In 506 patients (89.4%), surgery occurred within 24 hours of admission. Median duration of hospital stay in the total patient group was 6 days (IQR: 3).

Delirium
--------

A total of 196 patients (35%) had a delirium during hospital stay and follow-up. One patient was re-admitted within 1 week after discharge to the geriatric ward with delirium. Within the delirious group, 146 patients were women (74%). The median age was 85.5 (IQR: 8), *P*\<0.001. Preoperatively, 46 patients were delirious. In the majority of the patients with POD (112 patients, 74.7%), delirium started 1 day after surgery. The median delirium duration was 4 days (IQR: 4) ([Table 2](#t2-cia-12-421){ref-type="table"}).

Risk factors for delirium
-------------------------

Logistic regression was permitted because the rule of thumb was not violated (ten variables were found, and there were 196 events of delirium).

The following risk factors were significantly associated with incidence of delirium on univariate and multivariate analyses, respectively (adjusted for age): age (OR: 2.65 \[1.71--4.10\]), CCI (1.17 \[1.06--1.30\]), and ASA score (2.47 \[1.62--3.75\]), (0.45 \[0.30--0.70\]); the presence of dementia (0.25 \[0.16--0.35\]), (0.26 \[0.18--0.38\]); a previous delirium episode (0.29 \[0.20--0.44\]), (0.31 \[0.21--0.46\]); functional dependency (Katz-RC) (0.23 \[0.16--0.34\]), (0.26 \[0.18--0.40\]); postoperative hemoglobin level (0.77 \[0.66--0.92\]), (0.83 \[0.70--0.98\]); the amount of transfusions (1.23 \[1.06--1.43\]), (1.20 \[1.03--1.40\]); home care prior to admission (0.23 \[0.15--0.33\]), (0.26 \[0.17--0.38\]); institutionalization prior to admission (0.28 \[0.10--0.41\]), (0.31 \[0.21--0.45\]). [Table 2](#t2-cia-12-421){ref-type="table"} summarizes the risk factors for delirium.

The amount of packed cell transfusions in the delirious group ranged from 0 to 8 packed cells (median: 0, IQR: 1), whereas the amount of blood transfusions in the nondelirious group ranged from 0 to 6 packed cells (median: 0, IQR: 1), *P*=0.041.

### Perioperative risk factors

Osteosynthesis was performed in 266 cases (47%): a gamma nail in 173 patients (30.6%), a dynamic hip screw in 63 patients (11.1%), a Gannet in 18 patients (3.2%), and three Cancellous screws 12 patients (2.1%).

A total of 300 patients (53%) underwent prosthetic repair, of which 35 underwent total arthroplasty (6.2%) and 265 hemi-arthroplasty (47%).

No significant difference was found between the incidence of delirium and the use of either osteosynthesis or arthroplasty (*P*=0.738; [Table 2](#t2-cia-12-421){ref-type="table"}).

Postoperative outcome
---------------------

The following postoperative outcome were significantly correlated with delirium: longer length of hospital stay (median 6 days \[IQR: 6\], *P*=0.002), higher rate of complications (94 patients, 48.5%, *P*\<0.001) and higher incidence of mortality within 6 months (59 patients, 30.1%, *P*\<0.001).

A significantly higher rate of patients with a delirium were care-dependent and admitted to a nursing home (180 patients, 91.8%, *P*\<0.001). [Table 3](#t3-cia-12-421){ref-type="table"} shows the outcomes after delirium. Mortality is shown in the Kaplan--Meier curve ([Figure 1](#f1-cia-12-421){ref-type="fig"}).

Delirium and dementia
---------------------

A total of 168 patients (30%) had a form of dementia at admission. One hundred twenty-two patients (73%) had dementia, DOSS ≥3 during three work shifts in a row was described, presupposing a delirium. Geriatric consultation confirmed delirium in 97 (57.7%) of the 168 patients with dementia.

Preoperatively, 27 patients with dementia (16.1%) were delirious versus 19 patients (4.8%) without dementia, *P*\<0.001. Hence, the incidence of postoperative delirium was 35% (70 patients) in the patient group with dementia versus 21% (80 patients) in the group without dementia, *P*\<0.001.

The specific outcomes in patients with dementia and with a delirium are described in [Table 4](#t4-cia-12-421){ref-type="table"}.

Discussion
==========

The aim of this study was to add to the knowledge about risk factors of delirium and outcome after a delirium in elderly hip fracture patients who underwent acute surgical intervention. In this study, special attention was given to delirium superimposed on dementia.

Our study revealed a delirium incidence of 34.3%. The important risk factors appeared to be old age, high burden of comorbidity, dementia, previous delirium, functional dependency, low postoperative hemoglobin level, and high number of blood transfusions. Postoperatively, delirium was correlated with a higher incidence of complications, longer length of hospital stay, higher functional dependency, and a higher rate of mortality within 6 months. As 57.7% of the patients with dementia suffered from delirium, dementia appeared to be one of the most important risk factors for delirium. Patients with dementia and with delirium had a shorter admission duration and were more often institutionalized. Furthermore, a trend toward a higher incidence of 6-month mortality after an episode of delirium was noted.

The observed incidence of delirium in our study population (34%) and specifically in patients with dementia (58%) is in line with previous studies.[@b8-cia-12-421],[@b25-cia-12-421],[@b35-cia-12-421],[@b36-cia-12-421] Inouye et al described that delirium in the elderly population occurred in 13%--55%, with a higher percentage in surgical patients, especially hip fracture patients.[@b8-cia-12-421] Fick et al described 32% delirium in the specific group of patients with dementia. However, this was in nonsurgical patients.[@b25-cia-12-421] Striking is the fact that 46 of the 196 patients were delirious before surgery. In these cases, prevention of delirium was not possible.

The risk factors shown in our study that correlate with delirium should be assessed at admission to prevent delirium. Several risk factors in the current study are in line with previous research.[@b8-cia-12-421],[@b37-cia-12-421],[@b38-cia-12-421] Former studies used the ASA scale, as well as the CCI or Acute Physiology and Chronic Health Evaluation score. A high score, correlating with severe comorbidi-ties, was often found to be significantly related to POD.[@b35-cia-12-421] In the current study, a high score on the ASA scale and CCI is also reported as significantly related to POD.[@b22-cia-12-421],[@b35-cia-12-421],[@b39-cia-12-421]

Functional dependency was confirmed as a significant risk factor for delirium.[@b35-cia-12-421],[@b37-cia-12-421] However, Oh et al described that after multivariate analyses, functional impairment was not significantly correlated with delirium.[@b35-cia-12-421] These studies all used other measurements to define functional impairment or dependency. In the current study, functional dependency was described using the Katz-ADL. Patients often needed home care or were institutionalized prior to admission. In our opinion, these three findings are correlated.

In this study, a low postoperative hemoglobin (Hb) level was shown to be a risk factor for delirium. A low Hb level has not been associated with delirium in previous studies. However, former studies did describe a significantly higher incidence of delirium in elderly hospitalized anemic patients.[@b40-cia-12-421],[@b41-cia-12-421] This could be explained by the fact that after surgery, blood loss causes lower Hb levels but not necessarily anemia. In addition, the previous studies did not specifically describe the postoperative Hb levels, only whether a patient was anemic or not.

The daily consumption of alcohol, visual and hearing impairment are often described as risk factors for delirium.[@b8-cia-12-421],[@b39-cia-12-421] This was not confirmed in our study but is often described in general medicine.

This study also concluded that POD was highly correlated with short-term complications and long-term adverse outcomes. These outcomes are consistent with former research.[@b8-cia-12-421],[@b22-cia-12-421],[@b24-cia-12-421],[@b42-cia-12-421]

The POD was significantly associated with pulmonary and cardiac complications, urinary tract infections and bladder retention, ICU admission, length of hospital stay, functional dependency, and mortality.[@b42-cia-12-421],[@b43-cia-12-421] Besides comorbidity and the surgical procedure, these postoperative complications could have caused the delirious episode. The question remains which occurred first, the episode of delirium or the other postoperative complications.[@b7-cia-12-421],[@b8-cia-12-421]

It was expected that patients with dementia and with delirium would have worse outcome compared to nondemented patients. However, this was not confirmed in this study.

The non-demented patient group with a delirium had a significantly higher complication rate, a higher chance to be admitted to a new nursery home and a longer length of stay. Patients with dementia often quickly return to their previous nursery home and therefore have a shorter length of stay and a lower chance for other complications during hospital stay.

As described before, delirium, in general, has important short- and long-term adverse outcomes. Patients with dementia are vulnerable, due to their functional dependency and (often) poor nutritional state. This could lead to the expectation that the outcomes would be worse than the outcomes of nondemented patients.[@b44-cia-12-421] In addition, former research has clearly described the impact of delirium in patients with dementia and found that these patients required a longer hospital stay and showed greater functional impairment.[@b25-cia-12-421] However, functional impairment was described by Katz-ADL at follow-up, whereas our study described functional dependency using Katz-ADL and the need for care or institutionalization at admission and discharge. These outcomes found in our study are explained by the fact that most patients with dementia already were institutionalized and discharged early back to their nursing homes. By contrast, patients who were not demented and became delirious had to be admitted to a new nursing home for rehabilitation. Waiting lists for rehabilitation care in our setting are long, which explains a longer hospital stay and the increased risk for complications.

Mortality within 6 months was higher in delirious patients than in nondelirious patients, which is in line with former research.[@b9-cia-12-421],[@b11-cia-12-421] However, Dolan et al who also described an increased risk for mortality in delirious patients, described that after adjustment for confounders, delirium was no longer significantly associated with mortality.[@b10-cia-12-421]

The mortality rate in patients with dementia did not significantly differ from patients without dementia, which is in line with former research of Fick et al and McCusker et al.[@b25-cia-12-421],[@b45-cia-12-421] However, both studies were conducted in nonsurgical wards. The present article is one of a few to describe outcomes after delirium, with specific attention to patients with dementia, ie, delirium superimposed on dementia.

Limitations and strength
------------------------

This study has several limitations. This study was set up retrospectively and therefore not all predictors for delirium could be gathered and some were incomplete. Cognitive impairment or dementia was evaluated using medical notes. No distinction was made between severity of cognitive impairment. In addition, dementia often presents itself at admission, which might result in an underestimation of the number of patients with dementia in this study. Unfortunately, in our clinic informed-based interview like Informant Questionnaire on Cognitive Decline in the Elderly was not used to determine dementia. DOSS is officially a validated instrument for screening delirium and does not diagnose whether a patient is delirious, but it has a high sensitivity of 97%.[@b33-cia-12-421],[@b46-cia-12-421] DOSS has never been validated for patients with dementia, but geriatricians have diagnosed delirium in this patient category.[@b32-cia-12-421],[@b47-cia-12-421]

The strength of this study is that a great number of patients are investigated. The electronic patient file, which was implemented in 2013, was used to gather all data. In addition, also patients with dementia were included, which was often an exclusion criterion in other studies.[@b8-cia-12-421],[@b10-cia-12-421],[@b11-cia-12-421],[@b25-cia-12-421]

Conclusion
==========

Our results demonstrate the need for: 1) improvement of preventive care for delirium; 2) specific attention to patients with dementia for frailty and prevention of delirium; and 3) early diagnosis and treatment of delirium and its underlying causes.

It is crucial to identify and validate as many risk factors as possible to create a risk model for vulnerable patients of each specific patient group. In addition, more research is needed to define risk factors for delirium and to obtain knowledge on the outcomes after delirium, especially in patients with dementia.
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![Overall survival within 6 months. Delirium versus no delirium.\
**Notes:** Log rank\<0.001. ^a^Survival in the patient group without a delirium. ^b^Survival in the patient group with a delirium.\
**Abbreviation:** cum, cumulative.](cia-12-421Fig1){#f1-cia-12-421}

###### 

Baseline characteristics of the study population

  Patient characteristics                                   Total N=566   \%
  --------------------------------------------------------- ------------- ------
  Sex                                                                     
   Female                                                   425           75.0
   Male                                                     141           25.0
  Age, Median (IQR)                                         84 (9)        
  CCI, Median (IQR)                                         6 (2)         
  ASA score                                                               
   1                                                        12            2.1
   2                                                        159           27.8
   3                                                        364           63.6
   4                                                        31            5.5
  Medical history                                                         
   Contralateral hip fracture                               45            8.0
   Cardial                                                  248           44.0
   Pulmonal (COPD)                                          107           18.9
   Neurological[a](#tfn1-cia-12-421){ref-type="table-fn"}   203           35.9
   Renal insufficiency                                      82            14.5
   Delirium in medical history                              139           24.8
   Dementia                                                 168           29.7
   Diabetes                                                 133           23.5
   Osteoporosis                                             95            16.8
  BMI, Median (IQR)                                         23.6 (5.1)    
  SNAQ-RC                                                   0.54 (1.2)    
  0                                                         425           74.3
  1--2                                                      52            9.2
  ≥3                                                        63            11.1
  Katz-ADL, Median (IQR)                                    5 (3)         
  Daily use of alcohol                                      116           20.5
  Visual impairment                                         319           56.3
  Hearing impairment                                        223           39.4
  Preoperative Hb level (mmol/L), Median (IQR)              7.7 (1.4)     
  Nursing home prior to admission                           173           30.6
  Help at home prior to admission                           130           23.0
  Fracture type                                                           
   Intracapsular                                            329           58.0
   Intertrochanteric                                        206           36.4
   Subtrochanteric                                          31            5.5

**Note:**

Excluding dementia and delirium.

**Abbreviations:** ASA, American Society of Anesthesiology; BMI, body mass index; CCI, Charlson Comorbidity score; Hb, hemoglobin; Katz-ADL, Katz Index of Independence in Activities of Daily Living; COPD, chronic obstructive pulmonary disease; IQR, interquartile range; SD, standard deviation; SNAQ-RC, Short Nutritional Assessment Questionnaire for Residential Care.

###### 

Risk factors for delirium

  Delirium outcomes                                          No delirium   Delirium     Total        *P*-value                                            (uni) Odds ratio (CI 95%)   Adjusted odds ratio (CI 95%)
  ---------------------------------------------------------- ------------- ------------ ------------ ---------------------------------------------------- --------------------------- -------------------------------------------------------------
  Preoperative delirium                                      0 (0)         46 (23.5)    46                                                                                            
  Duration of delirium (days), Median (IQR)                  0 (0)         4 (4)        4 (4)                                                                                         
  Delirium at discharge                                      0 (0)         100 (51)     100                                                                                           
  Died while delirious                                       0 (0)         8 (4)        8                                                                                             
  **Risk factors**                                                                                                                                                                    
  Sex                                                                                                                                                     1.05 (0.71--1.60)           
   Female (ref)                                              279 (75.4)    146 (74.5)   425                                                                                           
   Male                                                      91 (24.6)     50 (25.5)    141          0.811                                                                            
  Age                                                                                                                                                     2.65 (1.71--4.10)           
   70--79                                                    126 (34.0)    32 (16.3)    158                                                                                           
   80+ (ref)                                                 244 (66.0)    164 (83.7)   408          \<0.001                                                                          
  Median (IQR)                                               83 (10)       85.5 (8)                  \<0.001[\^](#tfn7-cia-12-421){ref-type="table-fn"}   1.07 (1.04--1.10)           
  Burden of comorbidity                                                                                                                                                               
   CCI, Median (IQR)                                         5.0 (3)       6.0 (2)                   \<0.001[\^](#tfn7-cia-12-421){ref-type="table-fn"}   1.17 (1.06--1.30)           1.09 (0.98--1.21)
   ASA                                                                                                                                                                                
   1--2                                                      132 (35.7)    36 (18.4)    168                                                                                           
   3--4 (ref)                                                238 (64.3)    160 (81.6)   398          \<0.001                                              2.47 (1.62--3.75)           0.45 (0.30--0.70)[c](#tfn6-cia-12-421){ref-type="table-fn"}
  Medical history                                                                                                                                                                     
   Contralat hip fracture                                    28 (7.6)      17 (8.7)     45           0.644                                                1.16 (0.62--2.20)           
   Cardial                                                   164 (44.3)    85 (43.4)    248          0.827                                                0.96 (0.68--1.36)           
   Pulmonal (COPD)                                           68 (18.4)     39 (20.0)    107          0.660                                                1.10 (0.71--1.71)           
   Neurological[a](#tfn4-cia-12-421){ref-type="table-fn"}    127 (34.3)    76 (38.7)    203          0.293                                                1.21 (0.85--1.74)           
   Renal insufficiency                                       49 (13.2)     33 (16.8)    82           0.248                                                1.33 (0.82--2.14)           
   Dementia                                                  71 (19.2)     97 (49.5)    168          \<0.001                                              0.25 (0.16--0.35)           0.26 (0.18--0.38)[c](#tfn6-cia-12-421){ref-type="table-fn"}
   Previous delirium                                         61 (16.5)     78 (40.0)    139          \<0.001                                              0.29 (0.20--0.44)           0.31 (0.21--0.46)[c](#tfn6-cia-12-421){ref-type="table-fn"}
  Missing data (%)                                                                      6 (1.1)                                                                                       
   Diabetes                                                  82 (22.2)     51 (26.0)    133          0.303                                                1.24 (0.83--1.85)           
   Osteoporosis                                              70 (18.9)     25 (12.7)    95           0.062                                                0.63 (0.38--1.03)           
  BMI, Median (IQR)                                          23.6 (4.8)    23.5 (5.8)                0.561[\^](#tfn7-cia-12-421){ref-type="table-fn"}     0.99 (0.95--1.04)           
  SNAQ \<3                                                   317 (85.7)    160 (81.6)   479                                                                                           
  SNAQ ≥3 (ref)                                              36 (10.1)     25 (12.7)    61           0.240                                                1.39 (0.80--2.34)           
  Daily alcohol use                                          79 (21.3)     37 (18.9)    116          0.503                                                0.86 (0.56--1.33)           
  Visual impairment                                          203 (55)      116 (59.2)   319          0.325                                                1.20 (0.84--1.70)           
  Hearing impairment                                         137 (37)      86 (43.9)    223          0.113                                                1.33 (0.93--1.90)           
  Functional dependency                                                                                                                                                               
   Katz ≤ score 5                                            156 (42.1)    146 (75.0)   302          \<0.001                                              0.23 (0.16--0.34)           0.26 (0.18--0.40)[c](#tfn6-cia-12-421){ref-type="table-fn"}
   Katz ≤ score 2                                            55 (14.9)     83 (42.3)    138          \<0.001                                              0.23 (0.15--0.34)           0.24 (0.16--0.40)[c](#tfn6-cia-12-421){ref-type="table-fn"}
  Missing data (%)                                                                      8 (1.4)                                                                                       
  AO classification                                                                                                                                                                   
   31a1 (ref)                                                54 (14.6)     35 (17.9)    89           0.666                                                                            
   31a2                                                      62 (16.8)     33 (16.8)    95                                                                0.8 (0.5--1.5)              
   31a3                                                      30 (8.1)      19 (10.0)    49                                                                0.9 (0.4--1.8)              
   31b1                                                      53 (14.3)     21 (10.7)    74                                                                0.6 (0.3--1.2)              
   31b2                                                      81 (22.0)     37 (19.0)    118                                                               0.7 (0.4--1.3)              
   31b3                                                      90 (24.3)     51 (26.0)    141                                                               0.8 (0.5--1.5)              
  Preoperative anticoagulants                                201 (54.3)    105 (53.6)   306          0.864                                                0.97 (0.69--1.40)           
  Kind of anesthesia                                                                                 0.393                                                0.82 (0.53--1.28)           
   General (ref)                                             292 (78.9)    161 (82.1)   453                                                                                           
   Epidural                                                  77 (20.8)     35 (17.8)    112                                                                                           
  Duration of surgery *minutes*, Median (IQR)                77 (24)       69 (23)                   0.455[\^](#tfn7-cia-12-421){ref-type="table-fn"}     1.00                        
  Blood loss cc, Median (IQR)                                200 (200)     200 (150)                 0.564[\^](#tfn7-cia-12-421){ref-type="table-fn"}     1.00 (0.99--1.00)           
  Duration of admission until surgery                                                                                                                                                 
   \<24 hours (ref)                                          130 (35.1)    62 (31.6)    192          0.696                                                1.16 (0.801.70)             
   24--48 hours                                              202 (54.6)    112 (57.1)   314                                                                                           
   \>48 hours                                                38 (10.3)     22 (11.1)    60                                                                                            
  Operation description                                                                              0.738                                                0.94 (0.66--1.33)           
   Osteosynthesis (ref)                                      172 (46.5)    94 (35.3)    266                                                                                           
   Arthroplasty                                              198 (53.5)    102 (34.0)   300                                                                                           
  Hemoglobin level (mmol/L)                                                                                                                                                           
   Preoperative Hb level, Median (IQR)                       7.8 (1.3)     7.6 (1.3)                 0.051[\^](#tfn7-cia-12-421){ref-type="table-fn"}     0.86 (0.73--1.02)           
   Postoperative Hb level, Median (IQR)                      6.6 (1.5)     6.2 (1.6)                 0.002[\^](#tfn7-cia-12-421){ref-type="table-fn"}     0.77 (0.66--0.92)           0.83 (0.70--0.98)[c](#tfn6-cia-12-421){ref-type="table-fn"}
  Missing data (%)                                                                      *10 (1.7)*                                                                                    
  Blood transfused                                           99 (26.8)     66 (33.7)    165          0.085                                                1.40 (0.95--2.02)           
  Amount, Median (IQR)                                       0 (1)         0 (1)                     0.041[\^](#tfn7-cia-12-421){ref-type="table-fn"}     1.23 (1.06--1.43)           1.20 (1.03--1.40)[c](#tfn6-cia-12-421){ref-type="table-fn"}
  Home care prior to admission                                                                                                                                                        
   Care prior to admission                                   154 (41.6)    149 (76.0)   303          \<0.001                                              0.23 (0.15--0.33)           0.26 (0.17--0.38)[c](#tfn6-cia-12-421){ref-type="table-fn"}
   Nursing home                                              78 (21.1)     96 (48.5)    174          \<0.001                                              0.28 (0.10--0.41)           0.31 (0.21--0.45)[c](#tfn6-cia-12-421){ref-type="table-fn"}
   Care at home                                              76 (20.8)     53 (27.0)    129          0.079                                                0.71 (0.47--1.06)           
  Medication use[b](#tfn5-cia-12-421){ref-type="table-fn"}                                                                                                                            
   No medication (ref)                                       303 (82.0)    22 (11.2)    325          \<0.001                                                                          
   Prophylactic                                              62 (16.7)     71 (36.2)    133                                                               0.06 (0.04--0.11)           
   Therapeutic                                               5 (1.3)       103 (52.6)   108                                                               18.00 (6.88--47.0)          

**Notes:** Log regression for univariate measurements; CI 95%; adjusted OR for age. Katz ≤ score 5 physical impairment, Katz ≤ score 2 severe physical impairment.

Excluding dementia and delirium.

Haloperidol, seroquel, lorazepam.

Significant association with delirium when adjusted for age; Pearson chi-square test;

Mann--Whitney *U*-test; IQR: Interquartile range (of the median), missing data described in case of missing data and significant outcome.

**Abbreviations:** ASA, American Society of Anesthesiology; BMI, body mass index; cc, cubic centimeter; CI, confidence interval; CCI, Charlson comorbidity score; COPD, chronic obstructive pulmonary disease; Hb, hemoglobin; IQR, interquartile range; Katz, Katz Index of Independence; OR, odds ratio; SNAQ, Short Nutritional Assessment Questionnaire; uni, univariate odds ratio.

###### 

Outcomes in delirious patients versus patients without a delirium

  Postoperative outcomes                                            No delirium   Delirium     Total   *P*-value
  ----------------------------------------------------------------- ------------- ------------ ------- ---------------------------------------------------
  Length of ICU admission, Median (IQR)                             0 (0)         0 (0)                0.657[\^](#tfn11-cia-12-421){ref-type="table-fn"}
  ICU admission                                                     8 (2.1)       6 (3.0)      14      0.573[\*](#tfn10-cia-12-421){ref-type="table-fn"}
  ICU ≥2 days                                                       2 (0.5)       2 (1.0)      4       0.612[\*](#tfn10-cia-12-421){ref-type="table-fn"}
  Number of patients with a complication                            93 (25.1)     94 (48.0)    187     \<0.001
  Contralateral hip fracture within 6 months                        0 (0)         4 (2.0)      4       0.014[\*](#tfn10-cia-12-421){ref-type="table-fn"}
  Luxation                                                          5 (1.4)       1 (0.5)      6       0.670[\*](#tfn10-cia-12-421){ref-type="table-fn"}
  OSM outbreak                                                      5 (1.4)       4 (2.0)      9       0.505[\*](#tfn10-cia-12-421){ref-type="table-fn"}
  Cardiac complication                                              7 (1.8)       9 (4.6)      16      0.065
  Pulmonary complication                                            10 (2.7)      17 (8.7)     27      0.002
  Neurological[a](#tfn12-cia-12-421){ref-type="table-fn"}           4 (1.1)       7 (3.6)      10      0.037[\*](#tfn10-cia-12-421){ref-type="table-fn"}
  Renal function disorders                                          6 (1.6)       13 (6.6)     19      0.002
  Urinary tract infection                                           14 (3.8)      23 (117)     37      \<0.001
  Bladder retention                                                 15 (4.0)      17 (8.7)     32      0.024
  Infection                                                         1 (0.3)       2 (1.0)      3       0.276[\*](#tfn10-cia-12-421){ref-type="table-fn"}
  Postoperative bleeding                                            11 (2.9)      10 (5.1)     21      0.202
  Other complications[b](#tfn13-cia-12-421){ref-type="table-fn"}    25 (6.7)      30 (15.3)    55      0.001
  Hemodynamic instability                                           6 (1.6)       10 (5.1)     16      0.017
  Pneumonia                                                         6 (1.6)       12 (6.1)     18      0.004
  Myocardial infarction                                             2 (0.5)       1 (0.5)      3       1.000[\*](#tfn10-cia-12-421){ref-type="table-fn"}
  Cardiac decompensation                                            6 (1.6)       6 (3.0)      12      0.258[\*](#tfn10-cia-12-421){ref-type="table-fn"}
  Cardiac arrhythmia (AF)                                           4 (1.0)       6 (3.0)      10      0.102[\*](#tfn10-cia-12-421){ref-type="table-fn"}
  CVA/TIA                                                           3 (0.8)       7 (3.5)      10      0.037[\*](#tfn10-cia-12-421){ref-type="table-fn"}
  Nerve damage                                                      1 (0.3)       1 (0.5)      2       1.000[\*](#tfn10-cia-12-421){ref-type="table-fn"}
  Length of hospital stay, Median (IQR)                             5 (3)         6 (6)                0.001[\^](#tfn11-cia-12-421){ref-type="table-fn"}
  Mortality                                                                                            
   In-hospital mortality                                            4 (1.1)       7 (3.6)      11      0.055[\*](#tfn10-cia-12-421){ref-type="table-fn"}
   \<6-month mortality[c](#tfn14-cia-12-421){ref-type="table-fn"}   38 (10.4)     52 (27.5)    90      \<0.001
  Total mortality \<6 months                                        42 (11.4)     59 (30.1)    101     \<0.001
  Care after discharge                                                                                 
   Same residence                                                   151 (40.8)    95 (48.5)    246     0.080
   New residence                                                    215 (58.1)    94 (48.0)    309     0.021
   Home without care                                                26 (7.0)      1 (0.5)      27      0.001
   Home with care                                                   54 (14.6)     8 (4.1)      62      \<0.001
   Nursing home[d](#tfn15-cia-12-421){ref-type="table-fn"}          286 (77.3)    180 (91.8)   466     \<0.001

**Notes:** Pearson chi-square test;

Fisher's Exact Test;

Mann--Whitney *U*-test.

Excluding delirium.

Decubitus, ileus, scrotal abscess, electrolyte abnormalities, abdominal complaints, irregular glucoses values, iatrogenic complications during admission.

Excluding in-hospital mortality.

Revalidation, nursing home, or hospice.

**Abbreviations:** CVA/TIA, cerebrovascular accident or transient ischemic attack; ICU, intensive care unit; IQR, interquartile range; AF, atrial fibrillation; OSM, osteosyntheses material.

###### 

Delirium superimposed on dementia. Incidence and outcome

  Postoperative outcomes                                           No dementia                                   Dementia                *P*-value
  ---------------------------------------------------------------- --------------------------------------------- ----------------------- -----------------------------------------------------
  Delirium (n=196)                                                 99 (25.0)                                     97 (57.7)               \<0.001
  Preoperative delirium                                            19 (4.8)                                      27 (16.1)               \<0.001
  Length of delirium, Median (IQR)                                 4 (4)                                         3 (4)                   0.718[\^](#tfn21-cia-12-421){ref-type="table-fn"}
                                                                   **Delirium without dementia; N**=**99 (%)**   **DSD; N**=**97 (%)**   
  Number of patients with ≥ one complications                      57 (57.6)                                     37 (38.1)               0.006
  Cardiac complication                                             6 (6.0)                                       3 (3.1)                 0.498[\*](#tfn20-cia-12-421){ref-type="table-fn"}
  Pulmonary complication                                           13 (13.1)                                     4 (4.1)                 0.025
  Neurological[a](#tfn17-cia-12-421){ref-type="table-fn"}          5 (5.1)                                       3 (3.1)                 0.721[\*](#tfn20-cia-12-421){ref-type="table-fn"}
  Renal function disorders                                         8 (8.1)                                       5 (5.1)                 0.410
  Urinary tract infection                                          13 (13.1)                                     10 (10.3)               0.539
  Bladder retention                                                11 (11.1)                                     6 (6.2)                 0.221
  Other complications[b](#tfn18-cia-12-421){ref-type="table-fn"}   20 (20.2)                                     10 (10.3)               0.054
  Hemodynamic instability                                          6 (6.1)                                       4 (4.1)                 0.748[\*](#tfn20-cia-12-421){ref-type="table-fn"}
  Pneumonia                                                        9 (9.1)                                       3 (3.1)                 0.080
  Myocardial infarction                                            1 (1.0)                                       0 (0)                   1.000[\*](#tfn20-cia-12-421){ref-type="table-fn"}
  Cardiac decompensation                                           4 (4.0)                                       2 (2.0)                 0.683[\*](#tfn20-cia-12-421){ref-type="table-fn"}
  Cardiac rhythm disorder                                          2 (2.0)                                       4 (4.1)                 0.442[\*](#tfn20-cia-12-421){ref-type="table-fn"}
  CVA/TIA                                                          3 (3.0)                                       4 (4.1)                 0.719[\*](#tfn20-cia-12-421){ref-type="table-fn"}
  Length of hospital stay, Median (IQR)                            7 (6)                                         4 (4)                   \<0.001[\^](#tfn21-cia-12-421){ref-type="table-fn"}
  New residence                                                    64 (64.6)                                     29 (29.9)               \<0.001
  Nursing home                                                     86 (88)                                       92 (94.8)               0.053
  In-hospital mortality                                            5 (5.1)                                       2 (2.1)                 0.445[\*](#tfn20-cia-12-421){ref-type="table-fn"}
  \<6 month mortality[c](#tfn19-cia-12-421){ref-type="table-fn"}   21 (22.3)                                     31 (32.6)               0.113
  Total mortality \<6 months                                       26 (26.3)                                     33 (34.0)               0.236

**Notes:**

Excluding delirium.

Decubitus, ileus, scrotal abscess, electrolyte abnormalities, abdominal complaints, irregular glucose values, iatrogenic complications during admission.

Excluding in-hospital mortality; Pearson chi square test;

Fisher's Exact Test;

Mann--Whitney *U*-test.

**Abbreviations:** CVA/TIA, cerebrovascular accident or transient ischemic attack; DSD, delirium superimposed on dementia; IQR, interquartile range of the median.
